Experts Available for Comment On Direct-To-Consumer Advertising of Prescription Drugs

December 05, 2006
Michael Van Winkle

(Chicago, Illinois - December 5, 2006) The U.S. Government Accountability Office is expected to release a study on direct-to-consumer advertising (DTC) of prescription drugs in the coming weeks. The report comes in response to a June 2005 request by Senator Bill Frist that the GAO examine FDA regulation and oversight of DTC advertising and explore its "potential impact on utilization, health care spending, and patient education and awareness."

Below are links to several articles on the issue as well as contact information for experts available for interviews on DTC advertising.


AMA Too Timid on Direct to Consumer Advertising

By Dr. Richard Dolinar

Senior Fellow for The Heartland Institute and consultant to the pharmaceutical industry


Phone: 602/526-1235

Advertising Prescription Drugs: Is It Wasted?

By Joseph Bast

President of The Heartland Institute


Phone: 312/377-4000

Prescription Drug Advertising: Problem or Solution?

By Merrill Matthews

Director of the Council for Affordable Health Insurance


Phone: 703/836-6200

For more articles on DTC advertising visit PolicyBot™, The Heartland Institute's free online research database. Point your Web browser to

Other Expert Contacts

Sandy Liddy Bourne

Vice President for Policy and Strategy for The Heartland Institute

Phone: 703/799-0954 or 703/517-3585

John Garven

Policy Advisor to The Heartland Institute


Phone: 847/644-4496